Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Lincoln Pharmaceuticals Ltd

Pharmaceuticals & Biotechnology | Small Cap

Lincoln Pharmaceuticals Ltd Health Insights
Health Score : 7.31Health Score : 7.31

Lincoln Pharmaceuticals demonstrates strong financial health, particularly in solvency and growth. The company efficiently manages its debts and shows good growth in revenue, operating profit, and assets. Profitability is also a notable strength, with solid returns on capital, equity, and assets, along with healthy margins. However, there are areas needing attention. The company's efficiency ratios are weak, indicating challenges in managing assets and inventory. Financial ratios also show some concerns, particularly regarding capital expenditures and earnings per share. While liquidity is reasonably managed, there is room for improvement. Overall, Lincoln Pharmaceuticals presents a mixed picture, with significant strengths offset by identifiable weaknesses in operational efficiency and financial management.

Latest Report

View All
Q3 FY26 Earnings Conference Call

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Lincoln Pharmaceuticals Ltd Health Insights
Health Score : 7.31Health Score : 7.31

Lincoln Pharmaceuticals demonstrates strong financial health, particularly in solvency and growth. The company efficiently manages its debts and shows good growth in revenue, operating profit, and assets. Profitability is also a notable strength, with solid returns on capital, equity, and assets, along with healthy margins. However, there are areas needing attention. The company's efficiency ratios are weak, indicating challenges in managing assets and inventory. Financial ratios also show some concerns, particularly regarding capital expenditures and earnings per share. While liquidity is reasonably managed, there is room for improvement. Overall, Lincoln Pharmaceuticals presents a mixed picture, with significant strengths offset by identifiable weaknesses in operational efficiency and financial management.

Latest Report

View All
Q3 FY26 Earnings Conference Call

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

14.01

Undervalued

Industry Median

34.91

Undervalued
Undervalued

Small Cap Median

34.71

Undervalued

P/E RATIO

14.01

P/B RATIO

1.63

Undervalued

Industry Median

3.02

Undervalued
Undervalued

Small Cap Median

2.89

Undervalued

P/S RATIO

1.83

Neutral

Industry Median

2.06

Neutral
Neutral

Small Cap Median

1.96

Neutral

Others

Neutral

PEG RATIO

0.00

Neutral
Neutral

EV/EBITDA RATIO

9.13

Neutral

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹614.65 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Concall Report23rd Feb 26

Q3 FY26 Earnings Conference Call

BULLISH SENTIMENT

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company exhibits strong growth across various metrics, including revenue, operating profit, earnings per share, assets, and net income. This indicates a healthy expansion and effective management strategies. The consistent growth rates suggest the company is well-positioned for future success. Weighted average calculation method was used to arrive at the score.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate11.328.0513.927.237.7
Operating Profit Growth Rate10.34-6.2511.112-3.92
Earnings Per Share (EPS) Growth11.285.1127.97-11.746.74
Asset Growth Rate18.149.9319.2513.8611.67
Net Income Growth Rate11.295.827.4-11.837.32
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 3.60

The company's financial ratios reflect a mixed performance. While adjusted and cash earnings per share are at a lower level, book value per share is reasonable. Dividend per share distribution is also on the lower side, and capital expenditures suggest significant investments. This indicates potential areas needing attention to enhance overall financial performance. Weighted average calculation method was used to arrive at the score.

WeakAdjusted Earnings Per Share (Adjusted EPS)Weak
WeakCash Earnings Per Share (Cash EPS)Weak
WeakBook Value Per ShareWeak
WeakDividend Per Share (DPS)Weak
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)3436.54640.544
Cash Earnings Per Share (Cash EPS)38.5415247.551
Book Value Per Share216.5251296.5336379
Dividend Per Share (DPS)1.391.461.861.641.76
Capital Expenditures (CapEx)4613401924
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company's profitability ratios reflect a strong performance. Healthy gross profit margin, return on capital employed, return on equity, return on assets, operating margin, and net margin indicate efficient operations and effective management. These metrics collectively suggest the company is well-positioned to generate profits and create value. Weighted average calculation method was used to arrive at the score.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin18.6415.8815.3214.2912.52
Return on Capital Employed (ROCE)2422221716
Return on Equity (ROE)15.9414.5415.6812.211.61
Return on Assets (ROA)17.9815.3314.2912.811.01
Operating Margin20.3417.6517.2116.3714.61
Net Margin14.6214.3116.0113.1613.11
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 4.00

The company's efficiency ratios present a mixed picture. While inventory turnover is reasonable, fixed asset and capital turnover are relatively low, indicating underutilization of assets. Receivable days are high, suggesting challenges in collecting payments. Improving asset utilization and collection processes could enhance overall efficiency. Weighted average calculation method was used to arrive at the score.

WeakFixed Asset Turnover RatioWeak
AverageInventory Turnover RatioAverage
WeakReceivables Turnover RatioWeak
AverageDays Sales in Inventory RatioAverage
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio3.583.383.253.423.51
Inventory Turnover Ratio6.46.016.686.867.38
Receivables Turnover Ratio4.124.053.93.84.1
Days Sales in Inventory Ratio57.0360.7354.6453.2149.46
Receivable Days88.5990.1293.5996.0589.02
Capital Turnover Ratio1.091.020.980.930.89
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 10.00

The company demonstrates excellent coverage ratios, with a high interest coverage ratio and a strong equity dividend coverage ratio. This indicates the company can comfortably meet its interest obligations and provides substantial dividend coverage for its shareholders. This showcases financial stability and shareholder-friendly policies. Weighted average calculation method was used to arrive at the score.

ExcellentInterest Coverage RatioExcellent
ExcellentEquity Dividend Coverage RatioExcellent
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio975112355.5117
Equity Dividend Coverage Ratio2525252525
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company's solvency position is exceptionally strong, with no debt relative to its equity or assets. This indicates a very conservative financial structure and a low risk of financial distress. While this provides stability, the company might be missing opportunities to leverage debt for growth or increased returns. Weighted average calculation method was used to arrive at the score.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio00000
Debt to Equity Ratio00000
Equity Ratio11111
Debt To Asset Ratio00000
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 7.94

The company's liquidity position reflects a mixed performance. While current and quick ratios indicate a good ability to meet short-term obligations, the cash ratio suggests a lower proportion of cash readily available. The operating cash flow ratio, being at an average level, implies the company generates a reasonable amount of cash from its operations to cover its current liabilities. Generally, the company appears to maintain sufficient liquidity, balancing its current assets and liabilities effectively. Weighted average calculation method was used to arrive at the score.

ExcellentCurrent RatioExcellent
ExcellentQuick RatioExcellent
WeakCash RatioWeak
AverageOperating Cash Flow RatioAverage
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio2.873.993.543.53.67
Quick Ratio2.153.162.822.863.07
Cash Ratio0.190.40.130.180.25
Operating Cash Flow Ratio0.750.460.590.740.8
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 18 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Jagsonpal Pharmaceuticals Ltd8.5133.01Overvalued58.006.4243.00
2Accent Microcell Ltd7.9624.25Neutral57.0018.2844.00
3Lincoln Pharmaceuticals Ltd7.3114.01Neutral98.0043.8888.00
4NGL Fine Chem Ltd6.9839.22Overvalued73.0067.3948.00
5Syncom Formulations (India) Ltd6.9217.27Undervalued77.000.8176.00
6Medico Remedies Ltd6.6137.70Overvalued17.001.5813.00
7Kilitch Drugs (India) Ltd6.6121.54Neutral37.009.2730.00
8Kopran Ltd6.6025.82Neutral62.006.3026.00
9SMS Lifesciences India Ltd6.5921.20Undervalued45.0070.6819.00
10Hester Biosciences Ltd6.5431.74Neutral87.0061.2457.00
11Sigachi Industries Ltd6.4911.55Highly Undervalued54.00-2.08-83.00
12Sakar Healthcare Ltd5.8158.66Highly Overvalued69.0013.7030.00
13Medicamen Biotech Ltd5.7332.19Neutral20.006.9410.00
14Albert David Ltd5.63-272.47Neutral5.00-2.62-1.00
15Remus Pharmaceuticals Ltd5.3125.48Neutral57.0020.9746.00
16Ind-Swift Laboratories Ltd4.9539.28Neutral45.004.8941.00
17Venus Remedies Ltd4.8323.37Neutral147.0074.30103.00
18Wanbury Ltd4.6528.62Neutral88.0018.9343.00
Management Assessment Summary
OrangeBalanced Management

Lincoln Pharmaceuticals' management demonstrates a mixed performance. The increasing promoter holding and strong ROCE reflect confidence and efficient capital utilization. However, declining profit growth and fluctuating OPM raise concerns. Consistent sales growth and prudent debt management are positives, but working capital management needs improvement, leading to a mixed overall assessment.

Category Metric Value Assessment
PROS Promoter Holding 49.78% Increasing promoter confidence
Return on Capital Employed (ROCE) 22.53% Good Capital Utilization
CONS Compounded Profit Growth (TTM) -11% Declining Profit Growth
Operating Profit Margin (Latest Quarter) 16% Fluctuating Margins
AverageFinancial Performance & GrowthAverage
GoodCapital Efficiency & ReturnsGood
ExcellentFinancial Health & PrudenceExcellent
AverageStrategic & Operational IndicatorsAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Strategic & Operational Indicators

Risk Assessment Summary
OrangeBalanced Risk

Lincoln Pharmaceuticals faces moderate risks. While the company exhibits strengths in debt management and promoter holding, potential risks include fluctuating profit margins and inefficiencies in working capital management. The decrease in compounded profit growth and volatility in quarterly profit growth indicate an increased financial risk.

ExcellentOff-balance sheet exposure quantificationExcellent
ExcellentContingent liability evaluationExcellent
ExcellentAccounting quality red flagsExcellent
01.

Off-balance sheet exposure quantification

02.

Contingent liability evaluation

03.

Accounting quality red flags

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10615.26Bearish
  3. SMA 20619.54Bearish
  4. SMA 50630.84Bearish
  5. EMA 10616.27Bearish
  6. EMA 20620.16Bearish
  7. EMA 50627.14Bearish
  8. DEMA 10613.43Bullish
  9. DEMA 20612.97Bullish
  10. DEMA 50619.14Bearish
  11. TEMA 10615.00Bearish
  12. TEMA 20610.83Bullish
  13. TEMA 50618.36Bearish
  14. MACD-5.24Bullish
  15. ADX26.52Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI40.23Neutral
  3. CCI-35.43Neutral
  4. ROC 90.82Bullish
  5. ROC 14-3.43Bearish
  6. ROC 25-4.98Bearish
  7. Stoch K36.67Neutral
  8. Stoch D40.32Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper640.06Neutral
  3. BB Middle619.54Neutral
  4. BB Lower599.02Neutral
  5. ATR6.61Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI27.90Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10616.88Bearish
  3. SMA 20629.49Bearish
  4. SMA 50627.62Bearish
  5. EMA 10618.68Bearish
  6. EMA 20624.16Bearish
  7. EMA 50632.89Bearish
  8. DEMA 10611.99Bullish
  9. DEMA 20617.03Bearish
  10. DEMA 50619.65Bearish
  11. TEMA 10610.92Bullish
  12. TEMA 20612.94Bullish
  13. TEMA 50616.45Bearish
  14. MACD-6.02Bearish
  15. ADX21.02Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI40.89Neutral
  3. CCI-75.43Neutral
  4. ROC 9-2.62Bearish
  5. ROC 14-4.70Bearish
  6. ROC 25-2.58Bearish
  7. Stoch K24.37Neutral
  8. Stoch D25.84Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper659.01Neutral
  3. BB Middle629.48Neutral
  4. BB Lower599.96Neutral
  5. ATR9.77Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI33.96Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10629.51Bearish
  3. SMA 20630.48Bearish
  4. SMA 50656.16Bearish
  5. EMA 10623.94Bearish
  6. EMA 20630.04Bearish
  7. EMA 50641.31Bearish
  8. DEMA 10616.95Bearish
  9. DEMA 20619.09Bearish
  10. DEMA 50636.61Bearish
  11. TEMA 10613.15Bullish
  12. TEMA 20618.83Bearish
  13. TEMA 50N/AN/A
  14. MACD-8.06Bearish
  15. ADX16.87Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI41.37Neutral
  3. CCI-131.85Oversold
  4. ROC 9-3.35Bearish
  5. ROC 14-3.26Bearish
  6. ROC 253.54Bullish
  7. Stoch K21.18Neutral
  8. Stoch D19.61Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper653.53Neutral
  3. BB Middle630.48Neutral
  4. BB Lower607.44Neutral
  5. ATR16.67Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI44.00Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10631.96Bearish
  3. SMA 20652.45Bearish
  4. SMA 50640.83Bearish
  5. SMA 100602.99Bullish
  6. SMA 200559.99Bullish
  7. EMA 10633.16Bearish
  8. EMA 20641.52Bearish
  9. EMA 50636.53Bearish
  10. EMA 100611.25Bearish
  11. EMA 200589.00Bullish
  12. DEMA 10623.81Bearish
  13. DEMA 20632.13Bearish
  14. DEMA 50660.94Bearish
  15. DEMA 100652.83Bearish
  16. DEMA 200606.00Bullish
  17. TEMA 10624.32Bearish
  18. TEMA 20618.88Bearish
  19. TEMA 50651.37Bearish
  20. TEMA 100676.50Bearish
  21. TEMA 200637.46Bearish
  22. MACD-8.03Bearish
  23. ADX19.73Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI41.96Neutral
  3. CCI-63.58Neutral
  4. ROC 14-3.82Bearish
  5. ROC 25-8.60Bearish
  6. Stoch K34.78Neutral
  7. Stoch D34.53Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper757.10Neutral
  3. BB Middle652.45Neutral
  4. BB Lower547.80Neutral
  5. ATR30.65High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI47.79Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20610.13Bullish
  3. SMA 50558.57Bullish
  4. EMA 20611.41Bullish
  5. EMA 50585.54Bullish
  6. DEMA 20650.11Bearish
  7. DEMA 50595.49Bullish
  8. TEMA 20669.15Bearish
  9. TEMA 50614.59Bullish
  10. MACD29.40Bullish
  11. ADX35.31Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI54.39Neutral
  3. CCI102.24Overbought
  4. ROC 143.14Bullish
  5. ROC 2531.53Bullish
  6. Stoch K38.46Neutral
  7. Stoch D53.46Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper731.19Neutral
  3. BB Middle610.13Neutral
  4. BB Lower489.07Neutral
  5. ATR65.08Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI74.86Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6569.19Bullish
  3. SMA 12552.25Bullish
  4. SMA 24594.68Bullish
  5. EMA 6591.51Bullish
  6. EMA 12575.60Bullish
  7. EMA 24565.28Bullish
  8. DEMA 6621.62Bullish
  9. DEMA 12584.65Bullish
  10. DEMA 24597.87Bullish
  11. TEMA 6643.43Bearish
  12. TEMA 12598.60Bullish
  13. TEMA 24570.63Bullish
  14. MACD58.17Bearish
  15. ADX43.13Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI55.78Neutral
  3. CCI87.94Neutral
  4. ROC 254.69Bullish
  5. ROC 50103.78Bullish
  6. Stoch K16.94Oversold
  7. Stoch D34.45Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper741.38Neutral
  3. BB Middle581.23Neutral
  4. BB Lower421.07Neutral
  5. ATR110.26High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI89.77Overbought